Jefferson Update in Neurosurgery 2021
IMPORTANT BROWSER INFORMATION
This site will not work on Internet Explorer 8. Please use:
Advancements in the field of neurosurgery are occurring at an increasingly rapid rate. The integration of these advances into clinical practice often lags behind the rate at which they emerge in the literature. Therefore, a critical appraisal of the most recent and most influential advances in the various fields of neurosurgery is necessary to effectively incorporate these advances into clinical practice. Thomas Jefferson University is a world leader in neurosurgical research and practice. Current faculty and alumni from its residency and fellowship training programs are often on the cutting edge of neurosurgery.
In this virtual CME event, we will highlight the latest advances in the field of neurosurgery and identify ways in which practitioners from all fields can improve their practice and optimize the care for their patients by effectively integrating these changes into this practice. In addition to the major topics of neurovascular disease, neurooncology, spinal cord injury, neurotrauma, neuroimaging, and functional neurosurgery, we will also discuss how to evaluate one’s practice, improve patient safety, and limit medical errors using quality improvement tools. All practitioners who take care of patients with neurological illness could benefit from this event, including neurosurgeons, neurologists, neuro-intensivists, neuroradiologist, anesthesiologist, and practitioners who might refer patients for neurolosurgical care.
To successfully complete this activity, the required evaluation must be completed no later than Sunday, August 1, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This course is designed for physicians, physician assistants, nurse practitioners, and nurses.
Following this educational activity, learners will be able to:
- Evaluate the application of novel cerebrovascular treatment options for the management of common neurovascular conditions, including streamlined, multidisciplinary management of ischemic cerebrovascular disease, intracranial aneurysms, and arteriovenous malformations.
- Appraise novel therapies for neoplastic processes of the central nervous system, including complex cranial approaches, radiation therapy, and management of malignant neoplasms.
- Employ up-to-date treatment strategies for the management of spinal cord injury and degenerative disease of the spine
- Interpret the risks and benefits of various neuromodulatory, ablative, and resective treatment strategies for neurodegenerative conditions and seizure disorders for application into practice.
- Assess the quality of neurosurgical care in practice and identify patient care gaps and methods for improving patient safety, medical errors, and multidisciplinary communication.
- Employ a high-level of neurosurgical care during the COVID-19 pandemic, ensuring the safety of themselves and their patients without limiting their potential to deliver care.
Any sponsorship received for this educational activity will be published and announced prior to the start of the activity.
This draft agenda is subject to change, which may affect the credit count.
This CE activity is a live virtual meeting.
- Participants who register for the program will be sent an email with instructions for accessing the zoom webinar.
- Using the link provided in the email, participants must 'register' through zoom to access the program (via the zoom platform). Please use the same name as when registering for the activity to help with verifying participation.
- The zoom link will be active 30 minutes prior to the start of the program.
- Please click here to send an email if you encounter any problems accessing the program.
Conflict of interest
Thomas Jefferson University endorses the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.
All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.
M. Reid Gooch, MD-Activity Director
Chengyuan Wu, MD-Activity Director
Richard F. Schmidt, MD-Activity Director
Christopher J. Farrell, MD
Giuliana Labella, MSN
Caitlin Harley, MSN
Heather Brock, MSN
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Patient Safety and Risk Credit: The content for this activity qualifies for TBD PA Patient Safety and Risk credits.
Nurses: This activity awards 6.58 nursing contact hours.
Other Healthcare Professionals: This educational activity is designated for 6.75 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Per Jefferson policy, learners may add .25 credit (15 minutes) one time for completion of the required evaluation.
- 6.75 AMA PRA Category 1 Credit™
- 6.75 Attendance
- 6.58 CNE
- 13.25 PA
|Nurse/Other Health Professionals||$85|
|Jefferson Health Physicians, Nurse and Other Health Professionals||$60|
|All Residents and Fellows||$0|
To register online, you must have a CPD @ JeffLearn account.
Recording and Photography Strictly Prohibited
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.